Pin Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pin Sun has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Bo Li
Department of Medical Oncology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China
1 shared publication- Dongjie Zhang
Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China
1 shared publication Haibo Ni
Medical School of Nanjing University , 22 Hankou Road, Gulou District, Nanjing 210008
1 shared publicationHenggui Zhang
School of Physics and Astronomy, University of Manchester , Oxford Road, Manchester M13 9PL
1 shared publicationHuasen Jiang
College of Computer Science and Technology, Ocean University of China , 238 Songling Road, Laoshan District, Qingdao 266404
1 shared publicationHuijie Wang
Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China
1 shared publication
Latest Publications
- Open Access
- 30 April 2026
- Published by Wiley in Clinical Cardiology
- Vol. 49 (5) , e70285
Quantitative Assessment of Myocardial Perfusion in Physiological and Pathological Hypertrophy Using Myocardial Contrast Echocardiography
Objective: To quantitatively evaluate myocardial perfusion levels in patients with physiological and pathological myocardial hypertrophy using myocardial contrast echocardiography (MCE), and to investigate the diagnostic value of MCE parameters for differentiating between these conditions. Methods: From June 2023 to December 2024, 25 hypertensive patients with myocardial hypertrophy (pathological hypertrophy group), 25 healthy athletes (physiological hypertrophy group), and 25 healthy controls were enrolled. All participants underwent two‐dimensional echocardiography and MCE. Myocardial perfusion parameters—peak intensity ( A ‐value), wash‐in slope ( β ‐value), and myocardial blood flow (MBF)—were quantified using a 17‐segment model. Differences in perfusion parameters were compared, and receiver operating characteristic (ROC) curve analysis was performed to evaluate diagnostic efficacy. Results: Compared with controls, the physiological hypertrophy group showed significantly increased peak intensity ( A ‐value) and MBF ( p < 0.05), whereas the pathological hypertrophy group exhibited decreased A‐value, slope rate (β ‐value), and MBF ( p < 0.05). Intragroup segmental analysis revealed that in pathological hypertrophy, the basal segments had significantly lower A‐value and MBF compared to mid and apical segments ( p < 0.05). Intermural comparison demonstrated that in both control and physiological hypertrophy groups, the free wall had lower A ‐value and MBF than the septum ( p < 0.05). In contrast, pathological hypertrophy showed reduced A ‐value but increased β ‐value in the free wall ( p < 0.05). ROC curve analysis identified an optimal cutoff value of A > 8.13 dB (AUC = 0.904) for discriminating exercise‐induced physiological hypertrophy from hypertension‐induced pathological hypertrophy. Conclusion: MCE enables quantitative assessment of myocardial perfusion in hypertrophic patients. The A value, reflecting microvascular density, serves as a reliable discriminator between physiological and pathological hypertrophy.
- 30 April 2026
- Published by Wiley in Clinical Cardiology
- Vol. 49 (5) , e70285
Open AccessQuantitative Assessment of Myocardial Perfusion in Physiological and Pathological Hypertrophy Using Myocardial Contrast Echocardiography
Objective: To quantitatively evaluate myocardial perfusion levels in patients with physiological and pathological myocardial hypertrophy using myocardial contrast echocardiography (MCE), and to investigate the diagnostic value of MCE parameters for differentiating between these conditions. Methods: From June 2023 to December 2024, 25 hypertensive patients with myocardial hypertrophy (pathological hypertrophy group), 25 healthy athletes (physiological hypertrophy group), and 25 healthy controls were enrolled. All participants underwent two‐dimensional echocardiography and MCE. Myocardial perfusion parameters—peak intensity ( A ‐value), wash‐in slope ( β ‐value), and myocardial blood flow (MBF)—were quantified using a 17‐segment model. Differences in perfusion parameters were compared, and receiver operating characteristic (ROC) curve analysis was performed to evaluate diagnostic efficacy. Results: Compared with controls, the physiological hypertrophy group showed significantly increased peak intensity ( A ‐value) and MBF ( p < 0.05), whereas the pathological hypertrophy group exhibited decreased A‐value, slope rate (β ‐value), and MBF ( p < 0.05). Intragroup segmental analysis revealed that in pathological hypertrophy, the basal segments had significantly lower A‐value and MBF compared to mid and apical segments ( p < 0.05). Intermural comparison demonstrated that in both control and physiological hypertrophy groups, the free wall had lower A ‐value and MBF than the septum ( p < 0.05). In contrast, pathological hypertrophy showed reduced A ‐value but increased β ‐value in the free wall ( p < 0.05). ROC curve analysis identified an optimal cutoff value of A > 8.13 dB (AUC = 0.904) for discriminating exercise‐induced physiological hypertrophy from hypertension‐induced pathological hypertrophy. Conclusion: MCE enables quantitative assessment of myocardial perfusion in hypertrophic patients. The A value, reflecting microvascular density, serves as a reliable discriminator between physiological and pathological hypertrophy.
- Open Access
- 1 March 2026
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 27 (2)
Artificial intelligence-enabled multi-scale virtual cell: perspective, challenges, and opportunities
As the fundamental unit of life, cells coordinate biological activities through the interaction between microscopic molecular mechanisms and macroscopic tissue organization. Traditional research studies, experiments, and biochemical analyses, give rise to important insights, although they are restricted in spatiotemporal resolution and processing power, thereby precluding the understanding of dynamic cross-scale biological events . Breakthroughs in artificial intelligence (AI) have given birth to the AI virtual cell (AIVC) as a new way to do research. By integrating multi-omics data and mixing methods from multidisciplinary models, AIVC establishes a digital twin system to simulate cell functions and behaviors. AIVC still faces a number of pressing challenges that need to be addressed in its current development stage. In this review, we are proposing a unified definition and technical framework for AIVC and analyze in detail the cross-scale coupling mechanisms of the “gene–protein–pathway–cell” hierarchy. Furthermore, we decompose the technical construction framework of AIVC from cross-scale representation engineering, functional submodule design, and multi-component dynamic regulation mechanisms. Additionally, we summarize the existing models and datasets in the field to provide reference resources for researchers. Finally, we deeply discuss the challenges faced by AIVC, such as data heterogeneity and model interpretability, and aim to accelerate the research progress in the AIVC field while driving the life sciences to shift from observational analysis to a paradigm that integrates predictability and innovation. Despite being in the early stage, AIVC is a trending topic that has garnered widespread interest. This review aims to integrate existing models, datasets, and technical ideas to provide a unified framework for field development.
- 1 March 2026
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 27 (2)
Open AccessArtificial intelligence-enabled multi-scale virtual cell: perspective, challenges, and opportunities
As the fundamental unit of life, cells coordinate biological activities through the interaction between microscopic molecular mechanisms and macroscopic tissue organization. Traditional research studies, experiments, and biochemical analyses, give rise to important insights, although they are restricted in spatiotemporal resolution and processing power, thereby precluding the understanding of dynamic cross-scale biological events . Breakthroughs in artificial intelligence (AI) have given birth to the AI virtual cell (AIVC) as a new way to do research. By integrating multi-omics data and mixing methods from multidisciplinary models, AIVC establishes a digital twin system to simulate cell functions and behaviors. AIVC still faces a number of pressing challenges that need to be addressed in its current development stage. In this review, we are proposing a unified definition and technical framework for AIVC and analyze in detail the cross-scale coupling mechanisms of the “gene–protein–pathway–cell” hierarchy. Furthermore, we decompose the technical construction framework of AIVC from cross-scale representation engineering, functional submodule design, and multi-component dynamic regulation mechanisms. Additionally, we summarize the existing models and datasets in the field to provide reference resources for researchers. Finally, we deeply discuss the challenges faced by AIVC, such as data heterogeneity and model interpretability, and aim to accelerate the research progress in the AIVC field while driving the life sciences to shift from observational analysis to a paradigm that integrates predictability and innovation. Despite being in the early stage, AIVC is a trending topic that has garnered widespread interest. This review aims to integrate existing models, datasets, and technical ideas to provide a unified framework for field development.